Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
panobinostat/LBH589B
Locations
6
France
Novartis Investigative Site
Paris, France
Novartis Investigative Site
Paris, France
Novartis Investigative Site
Dresden, Germany
Novartis Investigative Site
Frankfurt, Germany
Novartis Investigative Site
Hanover, Germany
Novartis Investigative Site
Ulm, Germany
Start Date
September 1, 2009
Primary Completion Date
February 1, 2012
Completion Date
February 1, 2012
Last Updated
December 19, 2020
NCT06285890
NCT06220162
NCT04065399
NCT04628026
NCT06484062
NCT06994676
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions